Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Verger

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|March 21, 2022
Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma PatientsMarie Blonski, Tiphaine Obara, Cyril Brzenczek, et al.
Neurogenetics|July 5, 2022
Reduced penetrance of an eastern French mutation in ATL1 autosomal-dominant inheritance (SPG3A): extended phenotypic spectrum coupled with brain <sup>18</sup>F-FDG PETArmand Hocquel, Jean-Marie Ravel, Laetitia Lambert, et al.
Brain Communications|November 3, 2025
Mild cognitive dysfunction in hereditary spastic paraplegia 4 disease related to fluorodesoxyglucose cerebral positron emission tomographyRaphaël Miroglio, Armand Hocquel, Jean-Marie Ravel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2017
Added value of <sup>18</sup>F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic studyMathieu Ceccaldi, Thérèse Jonveaux, Antoine Verger, et al.
JACC. Advances|March 30, 2026
<sup>18</sup>F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac AmyloidosisTelma Sprauel, Emmanuel Itti, Laetitia Imbert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2024
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsyTatjana Traub-Weidinger, Javier Arbizu, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
Clinical impact of an explainable machine learning with amino acid PET imaging: application to the diagnosis of aggressive gliomaShamimeh Ahrari, Timothée Zaragori, Adeline Zinsz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|March 21, 2022
Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma PatientsMarie Blonski, Tiphaine Obara, Cyril Brzenczek, et al.
Neurogenetics|July 5, 2022
Reduced penetrance of an eastern French mutation in ATL1 autosomal-dominant inheritance (SPG3A): extended phenotypic spectrum coupled with brain <sup>18</sup>F-FDG PETArmand Hocquel, Jean-Marie Ravel, Laetitia Lambert, et al.
Brain Communications|November 3, 2025
Mild cognitive dysfunction in hereditary spastic paraplegia 4 disease related to fluorodesoxyglucose cerebral positron emission tomographyRaphaël Miroglio, Armand Hocquel, Jean-Marie Ravel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2017
Added value of <sup>18</sup>F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic studyMathieu Ceccaldi, Thérèse Jonveaux, Antoine Verger, et al.
JACC. Advances|March 30, 2026
<sup>18</sup>F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac AmyloidosisTelma Sprauel, Emmanuel Itti, Laetitia Imbert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2024
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsyTatjana Traub-Weidinger, Javier Arbizu, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
Clinical impact of an explainable machine learning with amino acid PET imaging: application to the diagnosis of aggressive gliomaShamimeh Ahrari, Timothée Zaragori, Adeline Zinsz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
Pageof 14